SCHEMBL20806089

SCHEMBL20806089

CNc1cccn(F)c1=O

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 3/20 0.36
TDP1 Q9NUW8 2/20 0.36
L3MBTL1 Q9Y468 2/20 0.36
RAB9A P51151 2/20 0.36
SMN1; SMN2 Q16637 2/20 0.36
EGFR P00533 1/20 0.36
PABPC1 P11940 1/20 0.36
MAPK1 P28482 1/20 0.36
KDM4E B2RXH2 3/20 0.34
POLB P06746 3/20 0.34
USP2 O75604 2/20 0.34
ALDH1A1 P00352 2/20 0.34
HPGD P15428 2/20 0.34
RECQL P46063 1/20 0.34
NPSR1 Q6W5P4 1/20 0.34
HSD17B10 Q99714 1/20 0.34
PKM P14618 2/20 0.34
HTR6 P50406 2/20 0.33
PDK1 Q15118 1/20 0.33
PDK2 Q15119 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9232313 0.77 TYK2 (0.40) MAPTTDP1L3MBTL1RAB9ASMN1; SMN2
SCHEMBL3108323 0.75 MMP2 (0.42) MAPTTDP1L3MBTL1RAB9ASMN1; SMN2
SCHEMBL12747503 0.72 TYK2 (0.40) MAPTTDP1L3MBTL1RAB9ASMN1; SMN2
SCHEMBL14467741 0.72 IDH1 (0.44) MAPTSMN1; SMN2MAPK1KDM4EPOLB
SCHEMBL20687681 0.71 GRM1 (0.49) MAPTMEN1KMT2AGRM1LMNA
SCHEMBL24880689 0.70 TYK2 (0.45)
SCHEMBL21227516 0.70 TYK2 (0.45)
SCHEMBL21285237 0.70 PTGS1 (0.44) MAPTSMN1; SMN2KDM4EALDH1A1MEN1
SCHEMBL20687683 0.68 TYK2 (0.44) MAPTL3MBTL1POLBALDH1A1MEN1
SCHEMBL20688057 0.68 TYK2 (0.45)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2019050924-A1 COMBINATION THERAPY FOR TREATING CANCER Epizyme, Inc. (US) 2019-03-14 WO disclosed